08:20-08:50 |
등록 |
|
08:50~09:00 |
환영인사 |
대한투석협회 회장 |
09:00~10:20 |
Session I. Infection in hemodialysis |
좌장 : 이중건 |
09:00~09:25 |
Prevention strategies for minimizing COVID-19 infection in dialysis facilities |
울산의대 유경돈 |
09:25~09:50 |
Outcomes in dialysis patients infected with COVID-19 patients |
한림의대 김도형 |
09:50~10:15 |
Infection control in dialysis facility |
이한규내과 이한규 |
10:15~10:20 |
Discussion |
|
10:20~10:40 |
Coffee Break |
|
10:40~12:00 |
Session II. Long term Complication in Dialysis Patients |
좌장 : 정윤철 |
10:40~11:05 |
Protein energy wasting syndrome |
차의대 김준철 |
11:05~11:30 |
Tissue calcification and PAD |
단국의대 이용진 |
11:30~11:55 |
Sudden death and cardiac arrhythmia in dialysis patients |
중앙의대 조준환 |
11:55~12:00 |
Discussion |
|
12:00~13:00 |
Lunch |
|
13:00~13:40 |
Session III. Sponsored Lecture |
좌장 : 안정경 |
13:00~13:40 |
Baxter – Medium cut-off dialyzer outcome |
더맑은내과 박민선 |
13:40~15:05 |
Session IV. Management of HD patients - update |
좌장 : 이숭구 |
13:40~14:05 |
Hyperkalemia management |
한림의대 기연경 |
14:05~14:30 |
Hyperphosphatemia management |
고려의대 김지은 |
14:30~14:55 |
Anemia management |
중앙의대 황진호 |
14:55~15:05 |
Discussion |
|
15:05~15:25 |
Coffee Break |
|
15:25~16:55 |
Session V. Non-dialysis, CKD patients |
좌장 : 김상욱 |
15:25~15:45 |
Uric acid lowering agent |
전남의대 오태렴 |
16:05~16:25 |
Indoxyl sulfate chelating agent |
한림의대 안정남 |
16:05~16:25 |
SGLT2 inhibitor |
연세의대 주영수 |
16:25~16:45 |
Non-steroidal mineralocorticoid receptor antagonists |
한림의대 안정남 |
16:45~16:55 |
Discussion |
|